Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
Clinical trial NCT05463354 · COMPLETED
Trial details
- NCT number
- NCT05463354
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2022-08-18
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.